世界のアルギナーゼ欠乏症治療薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Arginase Deficiency Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-105X01213
• 出版社/出版日：GlobalInfoResearch / 2021年5月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、103ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料では、アルギナーゼ欠乏症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アルギナーゼ欠乏症治療薬の種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・アルギナーゼ欠乏症治療薬の市場概要
・企業情報（企業概要、製品概要、販売量、価格、売上）：Helsinn Healthcare、Novartis Pharmaceuticals、Horizon Pharma、Medicis Pharmaceutical
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：経口、注射
・用途別分析2016年-2026年：病院、ドラッグストア、その他
・アルギナーゼ欠乏症治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・アルギナーゼ欠乏症治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・アルギナーゼ欠乏症治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・アルギナーゼ欠乏症治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン
・アルギナーゼ欠乏症治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Arginase Deficiency Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Arginase Deficiency Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Arginase Deficiency Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Arginase Deficiency Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Oral
Injection

Market segment by Application can be divided into
Hospital
Drugs Stores
Other

The key market players for global Arginase Deficiency Drugs market are listed below:
Helsinn Healthcare
Novartis Pharmaceuticals
Horizon Pharma
Medicis Pharmaceutical

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Arginase Deficiency Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Arginase Deficiency Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral
1.2.3 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Arginase Deficiency Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Drugs Stores
1.3.4 Other
1.4 Global Arginase Deficiency Drugs Market Size & Forecast
1.4.1 Global Arginase Deficiency Drugs Sales in Value (2016-2026))
1.4.2 Global Arginase Deficiency Drugs Sales in Volume (2016-2026)
1.4.3 Global Arginase Deficiency Drugs Price by Type (2016-2026) & (USD/MT)
1.5 Global Arginase Deficiency Drugs Production Capacity Analysis
1.5.1 Global Arginase Deficiency Drugs Total Production Capacity (2016-2026)
1.5.2 Global Arginase Deficiency Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Arginase Deficiency Drugs Market Drivers
1.6.2 Arginase Deficiency Drugs Market Restraints
1.6.3 Arginase Deficiency Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Helsinn Healthcare
2.1.1 Helsinn Healthcare Details
2.1.2 Helsinn Healthcare Major Business
2.1.3 Helsinn Healthcare Arginase Deficiency Drugs Product and Services
2.1.4 Helsinn Healthcare Arginase Deficiency Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Novartis Pharmaceuticals
2.2.1 Novartis Pharmaceuticals Details
2.2.2 Novartis Pharmaceuticals Major Business
2.2.3 Novartis Pharmaceuticals Arginase Deficiency Drugs Product and Services
2.2.4 Novartis Pharmaceuticals Arginase Deficiency Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Horizon Pharma
2.3.1 Horizon Pharma Details
2.3.2 Horizon Pharma Major Business
2.3.3 Horizon Pharma Arginase Deficiency Drugs Product and Services
2.3.4 Horizon Pharma Arginase Deficiency Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Medicis Pharmaceutical
2.4.1 Medicis Pharmaceutical Details
2.4.2 Medicis Pharmaceutical Major Business
2.4.3 Medicis Pharmaceutical Arginase Deficiency Drugs Product and Services
2.4.4 Medicis Pharmaceutical Arginase Deficiency Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Arginase Deficiency Drugs Sales by Manufacturer
3.1 Global Arginase Deficiency Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Arginase Deficiency Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Arginase Deficiency Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Arginase Deficiency Drugs Manufacturer Market Share
3.4.2 Top 6 Arginase Deficiency Drugs Manufacturer Market Share
3.5 Global Arginase Deficiency Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Arginase Deficiency Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Arginase Deficiency Drugs Market Size by Region
4.1.1 Global Arginase Deficiency Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Arginase Deficiency Drugs Revenue by Region (2016-2026)
4.2 North America Arginase Deficiency Drugs Revenue (2016-2026)
4.3 Europe Arginase Deficiency Drugs Revenue (2016-2026)
4.4 Asia-Pacific Arginase Deficiency Drugs Revenue (2016-2026)
4.5 South America Arginase Deficiency Drugs Revenue (2016-2026)
4.6 Middle East and Africa Arginase Deficiency Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Arginase Deficiency Drugs Sales in Volume by Type (2016-2026)
5.2 Global Arginase Deficiency Drugs Revenue by Type (2016-2026)
5.3 Global Arginase Deficiency Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Arginase Deficiency Drugs Sales in Volume by Application (2016-2026)
6.2 Global Arginase Deficiency Drugs Revenue by Application (2016-2026)
6.3 Global Arginase Deficiency Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Arginase Deficiency Drugs Sales by Type (2016-2026)
7.2 North America Arginase Deficiency Drugs Sales by Application (2016-2026)
7.3 North America Arginase Deficiency Drugs Market Size by Country
7.3.1 North America Arginase Deficiency Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Arginase Deficiency Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Arginase Deficiency Drugs Sales by Type (2016-2026)
8.2 Europe Arginase Deficiency Drugs Sales by Application (2016-2026)
8.3 Europe Arginase Deficiency Drugs Market Size by Country
8.3.1 Europe Arginase Deficiency Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Arginase Deficiency Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Arginase Deficiency Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Arginase Deficiency Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Arginase Deficiency Drugs Market Size by Region
9.3.1 Asia-Pacific Arginase Deficiency Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Arginase Deficiency Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Arginase Deficiency Drugs Sales by Type (2016-2026)
10.2 South America Arginase Deficiency Drugs Sales by Application (2016-2026)
10.3 South America Arginase Deficiency Drugs Market Size by Country
10.3.1 South America Arginase Deficiency Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Arginase Deficiency Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Arginase Deficiency Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Arginase Deficiency Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Arginase Deficiency Drugs Market Size by Country
11.3.1 Middle East & Africa Arginase Deficiency Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Arginase Deficiency Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Arginase Deficiency Drugs Typical Distributors
12.3 Arginase Deficiency Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Arginase Deficiency Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Arginase Deficiency Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Helsinn Healthcare Basic Information, Manufacturing Base and Competitors
Table 4. Helsinn Healthcare Major Business
Table 5. Helsinn Healthcare Arginase Deficiency Drugs Product and Services
Table 6. Helsinn Healthcare Arginase Deficiency Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Pharmaceuticals Major Business
Table 9. Novartis Pharmaceuticals Arginase Deficiency Drugs Product and Services
Table 10. Novartis Pharmaceuticals Arginase Deficiency Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Horizon Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Horizon Pharma Major Business
Table 13. Horizon Pharma Arginase Deficiency Drugs Product and Services
Table 14. Horizon Pharma Arginase Deficiency Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Medicis Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Medicis Pharmaceutical Major Business
Table 17. Medicis Pharmaceutical Arginase Deficiency Drugs Product and Services
Table 18. Medicis Pharmaceutical Arginase Deficiency Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global Arginase Deficiency Drugs Sales by Manufacturer (2019-2021e) & (K MT)
Table 20. Global Arginase Deficiency Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in Arginase Deficiency Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global Arginase Deficiency Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 23. Head Office and Arginase Deficiency Drugs Production Site of Key Manufacturer
Table 24. Global Arginase Deficiency Drugs Sales by Region (2016-2021e) & (K MT)
Table 25. Global Arginase Deficiency Drugs Sales by Region (2021-2026) & (K MT)
Table 26. Global Arginase Deficiency Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 27. Global Arginase Deficiency Drugs Revenue by Region (2021-2026) & (USD Million)
Table 28. Global Arginase Deficiency Drugs Sales by Type (2016-2021e) & (K MT)
Table 29. Global Arginase Deficiency Drugs Sales by Type (2021-2026) & (K MT)
Table 30. Global Arginase Deficiency Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 31. Global Arginase Deficiency Drugs Revenue by Type (2021-2026) & (USD Million)
Table 32. Global Arginase Deficiency Drugs Price by Type (2016-2021e) & (USD/MT)
Table 33. Global Arginase Deficiency Drugs Price by Type (2021-2026) & (USD/MT)
Table 34. Global Arginase Deficiency Drugs Sales by Application (2016-2021e) & (K MT)
Table 35. Global Arginase Deficiency Drugs Sales by Application (2021-2026) & (K MT)
Table 36. Global Arginase Deficiency Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 37. Global Arginase Deficiency Drugs Revenue by Application (2021-2026) & (USD Million)
Table 38. Global Arginase Deficiency Drugs Price by Application (2016-2021e) & (USD/MT)
Table 39. Global Arginase Deficiency Drugs Price by Application (2021-2026) & (USD/MT)
Table 40. North America Arginase Deficiency Drugs Sales by Country (2016-2021e) & (K MT)
Table 41. North America Arginase Deficiency Drugs Sales by Country (2021-2026) & (K MT)
Table 42. North America Arginase Deficiency Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 43. North America Arginase Deficiency Drugs Revenue by Country (2021-2026) & (USD Million)
Table 44. North America Arginase Deficiency Drugs Sales by Type (2016-2021e) & (K MT)
Table 45. North America Arginase Deficiency Drugs Sales by Type (2021-2026) & (K MT)
Table 46. North America Arginase Deficiency Drugs Sales by Application (2016-2021e) & (K MT)
Table 47. North America Arginase Deficiency Drugs Sales by Application (2021-2026) & (K MT)
Table 48. Europe Arginase Deficiency Drugs Sales by Country (2016-2021e) & (K MT)
Table 49. Europe Arginase Deficiency Drugs Sales by Country (2021-2026) & (K MT)
Table 50. Europe Arginase Deficiency Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 51. Europe Arginase Deficiency Drugs Revenue by Country (2021-2026) & (USD Million)
Table 52. Europe Arginase Deficiency Drugs Sales by Type (2016-2021e) & (K MT)
Table 53. Europe Arginase Deficiency Drugs Sales by Type (2021-2026) & (K MT)
Table 54. Europe Arginase Deficiency Drugs Sales by Application (2016-2021e) & (K MT)
Table 55. Europe Arginase Deficiency Drugs Sales by Application (2021-2026) & (K MT)
Table 56. Asia-Pacific Arginase Deficiency Drugs Sales by Region (2016-2021e) & (K MT)
Table 57. Asia-Pacific Arginase Deficiency Drugs Sales by Region (2021-2026) & (K MT)
Table 58. Asia-Pacific Arginase Deficiency Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 59. Asia-Pacific Arginase Deficiency Drugs Revenue by Region (2021-2026) & (USD Million)
Table 60. Asia-Pacific Arginase Deficiency Drugs Sales by Type (2016-2021e) & (K MT)
Table 61. Asia-Pacific Arginase Deficiency Drugs Sales by Type (2021-2026) & (K MT)
Table 62. Asia-Pacific Arginase Deficiency Drugs Sales by Application (2016-2021e) & (K MT)
Table 63. Asia-Pacific Arginase Deficiency Drugs Sales by Application (2021-2026) & (K MT)
Table 64. South America Arginase Deficiency Drugs Sales by Country (2016-2021e) & (K MT)
Table 65. South America Arginase Deficiency Drugs Sales by Country (2021-2026) & (K MT)
Table 66. South America Arginase Deficiency Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 67. South America Arginase Deficiency Drugs Revenue by Country (2021-2026) & (USD Million)
Table 68. South America Arginase Deficiency Drugs Sales by Type (2016-2021e) & (K MT)
Table 69. South America Arginase Deficiency Drugs Sales by Type (2021-2026) & (K MT)
Table 70. South America Arginase Deficiency Drugs Sales by Application (2016-2021e) & (K MT)
Table 71. South America Arginase Deficiency Drugs Sales by Application (2021-2026) & (K MT)
Table 72. Middle East & Africa Arginase Deficiency Drugs Sales by Country (2016-2021e) & (K MT)
Table 73. Middle East & Africa Arginase Deficiency Drugs Sales by Country (2021-2026) & (K MT)
Table 74. Middle East & Africa Arginase Deficiency Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 75. Middle East & Africa Arginase Deficiency Drugs Revenue by Country (2021-2026) & (USD Million)
Table 76. Middle East & Africa Arginase Deficiency Drugs Sales by Type (2016-2021e) & (K MT)
Table 77. Middle East & Africa Arginase Deficiency Drugs Sales by Type (2021-2026) & (K MT)
Table 78. Middle East & Africa Arginase Deficiency Drugs Sales by Application (2016-2021e) & (K MT)
Table 79. Middle East & Africa Arginase Deficiency Drugs Sales by Application (2021-2026) & (K MT)
Table 80. Direct Channel Pros & Cons
Table 81. Indirect Channel Pros & Cons
Table 82. Arginase Deficiency Drugs Typical Distributors
Table 83. Arginase Deficiency Drugs Typical Customers
List of Figures
Figure 1. Arginase Deficiency Drugs Picture
Figure 2. Global Arginase Deficiency Drugs Sales Market Share by Type in 2020
Figure 3. Oral
Figure 4. Injection
Figure 5. Global Arginase Deficiency Drugs Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Drugs Stores
Figure 8. Other
Figure 9. Global Arginase Deficiency Drugs Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 10. Global Arginase Deficiency Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Arginase Deficiency Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Arginase Deficiency Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Arginase Deficiency Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Arginase Deficiency Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Arginase Deficiency Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Arginase Deficiency Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Arginase Deficiency Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Arginase Deficiency Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Arginase Deficiency Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Arginase Deficiency Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Arginase Deficiency Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Arginase Deficiency Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Arginase Deficiency Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Arginase Deficiency Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Arginase Deficiency Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Arginase Deficiency Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Arginase Deficiency Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Arginase Deficiency Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Arginase Deficiency Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Arginase Deficiency Drugs Sales (2016-2026) & (K MT)
Figure 31. Global Arginase Deficiency Drugs Production Capacity (2016-2026) & (K MT)
Figure 32. Global Arginase Deficiency Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Arginase Deficiency Drugs Market Drivers
Figure 34. Arginase Deficiency Drugs Market Restraints
Figure 35. Arginase Deficiency Drugs Market Trends
Figure 36. Global Arginase Deficiency Drugs Sales Market Share by Manufacturer in 2020
Figure 37. Global Arginase Deficiency Drugs Revenue Market Share by Manufacturer in 2020
Figure 38. Arginase Deficiency Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Arginase Deficiency Drugs Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Arginase Deficiency Drugs Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Arginase Deficiency Drugs Sales Market Share by Region (2016-2026)
Figure 42. Global Arginase Deficiency Drugs Revenue Market Share by Region (2016-2026)
Figure 43. North America Arginase Deficiency Drugs Revenue (2016-2026) & (USD Million)
Figure 44. Europe Arginase Deficiency Drugs Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Arginase Deficiency Drugs Revenue (2016-2026) & (USD Million)
Figure 46. South America Arginase Deficiency Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Arginase Deficiency Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Global Arginase Deficiency Drugs Sales Market Share by Type (2016-2026)
Figure 49. Global Arginase Deficiency Drugs Revenue Market Share by Type (2016-2026)
Figure 50. Global Arginase Deficiency Drugs Price by Type (2016-2026) & (USD/MT)
Figure 51. Global Arginase Deficiency Drugs Sales Market Share by Application (2016-2026)
Figure 52. Global Arginase Deficiency Drugs Revenue Market Share by Application (2016-2026)
Figure 53. Global Arginase Deficiency Drugs Price by Application (2016-2026) & (USD/MT)
Figure 54. North America Arginase Deficiency Drugs Sales Market Share by Country (2016-2026)
Figure 55. North America Arginase Deficiency Drugs Revenue Market Share by Country (2016-2026)
Figure 56. North America Arginase Deficiency Drugs Sales Market Share by Type (2016-2026)
Figure 57. North America Arginase Deficiency Drugs Sales Market Share by Application (2016-2026)
Figure 58. Europe Arginase Deficiency Drugs Sales Market Share by Country (2016-2026)
Figure 59. Europe Arginase Deficiency Drugs Revenue Market Share by Country (2016-2026)
Figure 60. Europe Arginase Deficiency Drugs Sales Market Share by Type (2016-2026)
Figure 61. Europe Arginase Deficiency Drugs Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Arginase Deficiency Drugs Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Arginase Deficiency Drugs Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Arginase Deficiency Drugs Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Arginase Deficiency Drugs Sales Market Share by Application (2016-2026)
Figure 66. South America Arginase Deficiency Drugs Sales Market Share by Country (2016-2026)
Figure 67. South America Arginase Deficiency Drugs Revenue Market Share by Country (2016-2026)
Figure 68. South America Arginase Deficiency Drugs Sales Market Share by Type (2016-2026)
Figure 69. South America Arginase Deficiency Drugs Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Arginase Deficiency Drugs Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Arginase Deficiency Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Arginase Deficiency Drugs Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Arginase Deficiency Drugs Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source

Global Epoprostenol Sodium Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X06360 2021年5月 100Pages
当調査資料では、エポプロステノールナトリウム薬品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。エポプロステノールナトリウム薬品の種類別市場規模（0.5mg、1.5mg）、用途別市場規模（病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、...

世界の泌尿器科用薬市場 2021：企業別、地域別、種類・用途別

Global Urology Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X14842 2021年5月 84Pages
当調査資料では、泌尿器科用薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。泌尿器科用薬の種類別市場規模（Α（アルファ）遮断薬、5α-レダクターゼ阻害薬）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界の抗コリン作用乗物酔い止め薬市場 2021：企業別、地域別、種類・用途別

Global Anticholinergic Travel Sickness Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X01057 2021年5月 109Pages
当調査資料では、抗コリン作用乗物酔い止め薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗コリン作用乗物酔い止め薬の種類別市場規模（大人用、子供用）、用途別市場規模（病院、薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本...

世界のブドウ球菌感染症治療薬市場 2021：企業別、地域別、種類・用途別

Global Staphylococcal Infection Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X19640 2021年5月 104Pages
当調査資料では、ブドウ球菌感染症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ブドウ球菌感染症治療薬の種類別市場規模（ベータラクタム、ペプチド、キノロン、その他）、用途別市場規模（病院、薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ...

世界のアルギニン血症治療薬市場 2021：企業別、地域別、種類・用途別

Global Argininemia Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X01214 2021年5月 105Pages
当調査資料では、アルギニン血症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アルギニン血症治療薬の種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南...

世界の出血性脳卒中治療薬市場 2021：企業別、地域別、種類・用途別

Global Haemorrhagic Stroke Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X08097 2021年5月 108Pages
当調査資料では、出血性脳卒中治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。出血性脳卒中治療薬の種類別市場規模（降圧薬、抗凝固薬、利尿薬、抗けいれん薬、その他）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、...

世界の女性用不妊治療薬市場 2021：企業別、地域別、種類・用途別

Global Female Infertility Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X06729 2021年5月 104Pages
当調査資料では、女性用不妊治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。女性用不妊治療薬の種類別市場規模（非経口、経口、その他）、用途別市場規模（不妊治療クリニック、病院、クライオバンク）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中...

アデノシンデアミナーゼ欠損症薬の世界市場2018-2025 Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide.In 2018, the global Adenosine Deaminase Deficiency Drugs market size was xx million US$ and is forecast to xx million US in 2025, gro…
第VIII因子不足治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endotheli…
第IX因子不足治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. Scope of the Report: This report studies the Factor IX Deficiency Treatment market status and outlook of Global and major regio…
アデノシンデアミナーゼ欠損症の世界市場2018-2025 Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide.In 2018, the global Adenosine Deaminase Deficiency market size was xx million US$ and is forecast to xx million US in 2025, growing a…
アデノシンデアミナーゼ欠損症治療の世界市場2018-2025 Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide.In 2018, the global Adenosine Deaminase Deficiency Therapeutic market size was xx million US$ and is forecast to xx million US in 202…